Subunit-Specific Role of NF-κB in Cancer

Kaltschmidt B, Greiner J, Kadhim H, Kaltschmidt C (2018)
Biomedicines 6(2): 44.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Abstract / Bemerkung
The transcription factor NF-kB is a key player in inflammation, cancer development, and progression. NF-kB stimulates cell proliferation, prevents apoptosis, and could promote tumor angiogenesis as well as metastasis. Extending the commonly accepted role of NF-kB in cancer formation and progression, different NF-kB subunits have been shown to be active and of particular importance in distinct types of cancer. Here, we summarize overexpression data of the NF-kB subunits RELA, RELB, and c-REL (referring to the v-REL, which is the oncogene of Reticuloendotheliosis virus strain T) as well as of their upstream kinase inhibitor, namely inhibitor of kB kinases (IKK), in different human cancers, assessed by database mining. These data argue against a universal mechanism of cancer-mediated activation of NF-kB, and suggest a much more elaborated mode of NF-kB regulation, indicating a tumor type-specific upregulation of the NF-kB subunits. We further discuss recent findings showing the diverse roles of NF-kB signaling in cancer development and metastasis in a subunit-specific manner, emphasizing their specific transcriptional activity and the role of autoregulation. While non-canonical NF-kB RELB signaling is described to be mostly present in hematological cancers, solid cancers reveal constitutive canonical NF-kB RELA or c-REL activity. Providing a linkage to cancer therapy, we discuss the recently described pivotal role of NF-kB c-REL in regulating cancer-targeting immune responses. In addition, current strategies and ongoing clinical trials are summarized, which utilize genome editing or drugs to inhibit the NF-kB subunits for cancer treatment.
NF-kB; RELA; cREL; RELB; tumor; cancer; transformation; inflammation; gene expression; tumor necrosis factor; Treg
Page URI


Kaltschmidt B, Greiner J, Kadhim H, Kaltschmidt C. Subunit-Specific Role of NF-κB in Cancer. Biomedicines. 2018;6(2): 44.
Kaltschmidt, B., Greiner, J., Kadhim, H., & Kaltschmidt, C. (2018). Subunit-Specific Role of NF-κB in Cancer. Biomedicines, 6(2), 44.
Kaltschmidt, Barbara, Greiner, Johannes, Kadhim, Hussamadin, and Kaltschmidt, Christian. 2018. “Subunit-Specific Role of NF-κB in Cancer”. Biomedicines 6 (2): 44.
Kaltschmidt, B., Greiner, J., Kadhim, H., and Kaltschmidt, C. (2018). Subunit-Specific Role of NF-κB in Cancer. Biomedicines 6:44.
Kaltschmidt, B., et al., 2018. Subunit-Specific Role of NF-κB in Cancer. Biomedicines, 6(2): 44.
B. Kaltschmidt, et al., “Subunit-Specific Role of NF-κB in Cancer”, Biomedicines, vol. 6, 2018, : 44.
Kaltschmidt, B., Greiner, J., Kadhim, H., Kaltschmidt, C.: Subunit-Specific Role of NF-κB in Cancer. Biomedicines. 6, : 44 (2018).
Kaltschmidt, Barbara, Greiner, Johannes, Kadhim, Hussamadin, and Kaltschmidt, Christian. “Subunit-Specific Role of NF-κB in Cancer”. Biomedicines 6.2 (2018): 44.

10 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.
Tabolacci C, De Martino A, Mischiati C, Feriotto G, Beninati S., Med Sci (Basel) 7(2), 2019
PMID: 30691081
A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells.
Kaltschmidt C, Banz-Jansen C, Benhidjeb T, Beshay M, Förster C, Greiner J, Hamelmann E, Jorch N, Mertzlufft F, Pfitzenmaier J, Simon M, Schulte Am Esch J, Vordemvenne T, Wähnert D, Weissinger F, Wilkens L, Kaltschmidt B., Cancers (Basel) 11(5), 2019
PMID: 31083587
The Unsolved Puzzle of c-Rel in B Cell Lymphoma.
Kober-Hasslacher M, Schmidt-Supprian M., Cancers (Basel) 11(7), 2019
PMID: 31277480
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome.
Mihai S, Codrici E, Popescu ID, Enciu AM, Albulescu L, Necula LG, Mambet C, Anton G, Tanase C., J Immunol Res 2018(), 2018
PMID: 30271792
Possible Mechanisms of Green Tea and Its Constituents against Cancer.
Shirakami Y, Shimizu M., Molecules 23(9), 2018
PMID: 30205425
NO-Donor Nitrosyl Iron Complex with 2-Aminophenolyl Ligand Induces Apoptosis and Inhibits NF-κB Function in HeLa Cells.
Stupina T, Balakina A, Kondrat'eva T, Kozub G, Sanina N, Terent'ev A., Sci Pharm 86(4), 2018
PMID: 30314357
Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways.
Chirumbolo S, Bjørklund G, Lysiuk R, Vella A, Lenchyk L, Upyr T., Int J Mol Sci 19(11), 2018
PMID: 30424557
RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells.
Zhou X, Shan Z, Yang H, Xu J, Li W, Guo F., Cancer Cell Int 18(), 2018
PMID: 30473630
Insights Into SND1 Oncogene Promoter Regulation.
Ochoa B, Chico Y, Martínez MJ., Front Oncol 8(), 2018
PMID: 30619748

76 References

Daten bereitgestellt von Europe PubMed Central.

JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework.
Khan A, Fornes O, Stigliani A, Gheorghe M, Castro-Mondragon JA, van der Lee R, Bessy A, Cheneby J, Kulkarni SR, Tan G, Baranasic D, Arenillas DJ, Sandelin A, Vandepoele K, Lenhard B, Ballester B, Wasserman WW, Parcy F, Mathelier A., Nucleic Acids Res. 46(D1), 2018
PMID: 29140473
Transcription of the RelB gene is regulated by NF-kappaB.
Bren GD, Solan NJ, Miyoshi H, Pennington KN, Pobst LJ, Paya CV., Oncogene 20(53), 2001
PMID: 11753650
COSMIC: exploring the world's knowledge of somatic mutations in human cancer.
Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, Kok CY, Jia M, De T, Teague JW, Stratton MR, McDermott U, Campbell PJ., Nucleic Acids Res. 43(Database issue), 2014
PMID: 25355519
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.
Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z, Li J, Peng B, Fleming JB, Wang H, Liu J, Lemischka IR, Hung MC, Chiao PJ., Cancer Cell 21(1), 2012
PMID: 22264792
Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.
Chen FE, Huang DB, Chen YQ, Ghosh G., Nature 391(6665), 1998
PMID: 9450761
Regulatory T cells in tumor immunity.
Nishikawa H, Sakaguchi S., Int. J. Cancer 127(4), 2010
PMID: 20518016
1,8-Cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity.
Greiner JF, Muller J, Zeuner MT, Hauser S, Seidel T, Klenke C, Grunwald LM, Schomann T, Widera D, Sudhoff H, Kaltschmidt B, Kaltschmidt C., Biochim. Biophys. Acta 1833(12), 2013
PMID: 23872422
Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.
Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM., Science 284(5412), 1999
PMID: 10195897
Identification of neural crest-derived stem cell-like cells from the corneal limbus of juvenile mice.
Brandl C, Florian C, Driemel O, Weber BH, Morsczeck C., Exp. Eye Res. 89(2), 2009
PMID: 19328783
Thalidomide in cancer.
Singhal S, Mehta J., Biomed. Pharmacother. 56(1), 2002
PMID: 11905508
Isolation of multipotent adult stem cells from the dermis of mammalian skin.
Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD., Nat. Cell Biol. 3(9), 2001
PMID: 11533656
Isolation of multipotent stem cells from adult rat periodontal ligament by neurosphere-forming culture system.
Techawattanawisal W, Nakahama K, Komaki M, Abe M, Takagi Y, Morita I., Biochem. Biophys. Res. Commun. 357(4), 2007
PMID: 17459343
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M., Science 293(5534), 2001
PMID: 11520989
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, Van Wier S, Tiedemann R, Shi CX, Sebag M, Braggio E, Henry T, Zhu YX, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA, Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn L, Barrett M, Valdez R, Trent J, Stewart AK, Carpten J, Bergsagel PL., Cancer Cell 12(2), 2007
PMID: 17692805
IKK1/2 protect human cells from TNF-mediated RIPK1-dependent apoptosis in an NF-κB-independent manner.
Slotta C, Storm J, Pfisterer N, Henkel E, Kleinwachter S, Pieper M, Ruiz-Perera LM, Greiner JFW, Kaltschmidt B, Kaltschmidt C., Biochim Biophys Acta Mol Cell Res 1865(8), 2018
PMID: 29630899
Structural and functional characterization of the promoter regions of the NFKB2 gene.
Lombardi L, Ciana P, Cappellini C, Trecca D, Guerrini L, Migliazza A, Maiolo AT, Neri A., Nucleic Acids Res. 23(12), 1995
PMID: 7541912
Development of the proteasome inhibitor Velcade (Bortezomib).
Adams J, Kauffman M., Cancer Invest. 22(2), 2004
PMID: 15199612
The diverse and complex roles of NF-κB subunits in cancer.
Perkins ND., Nat. Rev. Cancer 12(2), 2012
PMID: 22257950
Inflammation meets cancer, with NF-κB as the matchmaker.
Ben-Neriah Y, Karin M., Nat. Immunol. 12(8), 2011
PMID: 21772280
Apoptosis effects of Xrel3 c-Rel/Nuclear Factor-kappa B homolog in human cervical cancer cells.
Shehata M, Shehata M, Shehata F, Pater A., Cell Biol. Int. 29(6), 2005
PMID: 16054560
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.
Gannon PO, Lessard L, Stevens LM, Forest V, Begin LR, Minner S, Tennstedt P, Schlomm T, Mes-Masson AM, Saad F., Eur. J. Cancer 49(10), 2013
PMID: 23541563
Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.
Shukla S, MacLennan GT, Fu P, Patel J, Marengo SR, Resnick MI, Gupta S., Neoplasia 6(4), 2004
PMID: 15256061
NF-κB, an active player in human cancers.
Xia Y, Shen S, Verma IM., Cancer Immunol Res 2(9), 2014
PMID: 25187272
Telomerase directly regulates NF-κB-dependent transcription.
Ghosh A, Saginc G, Leow SC, Khattar E, Shin EM, Yan TD, Wong M, Zhang Z, Li G, Sung WK, Zhou J, Chng WJ, Li S, Liu E, Tergaonkar V., Nat. Cell Biol. 14(12), 2012
PMID: 23159929
Inflammation and colon cancer.
Terzic J, Grivennikov S, Karin E, Karin M., Gastroenterology 138(6), 2010
PMID: 20420949
A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA, Kaergel E, Heinig M, Fontaine JF, Patone G, Muro EM, Mathas S, Hummel M, Andrade-Navarro MA, Hubner N, Scheidereit C., Genome Med 8(1), 2016
PMID: 26988706
Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
Alberti C, Pinciroli P, Valeri B, Ferri R, Ditto A, Umezawa K, Sensi M, Canevari S, Tomassetti A., Oncogene 31(37), 2011
PMID: 22158046
Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice.
Vlantis K, Wullaert A, Sasaki Y, Schmidt-Supprian M, Rajewsky K, Roskams T, Pasparakis M., J. Clin. Invest. 121(7), 2011
PMID: 21701067
Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators.
Kaltschmidt B, Kaltschmidt C, Hehner SP, Droge W, Schmitz ML., Oncogene 18(21), 1999
PMID: 10359527
Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling.
Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI., Nat Commun 2(), 2011
PMID: 21245843
NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer.
Grinberg-Bleyer Y, Oh H, Desrichard A, Bhatt DM, Caron R, Chan TA, Schmid RM, Klein U, Hayden MS, Ghosh S., Cell 170(6), 2017
PMID: 28886380
Thalidomide treatment in multiple myeloma.
Strasser K, Ludwig H., Blood Rev. 16(4), 2002
PMID: 12350364
Hallmarks of cancer: the next generation.
Hanahan D, Weinberg RA., Cell 144(5), 2011
PMID: 21376230
The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation.
Ten RM, Paya CV, Israel N, Le Bail O, Mattei MG, Virelizier JL, Kourilsky P, Israel A., EMBO J. 11(1), 1992
PMID: 1740105
Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes.
Serfling E, Barthelmas R, Pfeuffer I, Schenk B, Zarius S, Swoboda R, Mercurio F, Karin M., EMBO J. 8(2), 1989
PMID: 2542017
Structure and autoregulation of the c-rel promoter.
Hannink M, Temin HM., Oncogene 5(12), 1990
PMID: 2284104
The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.
Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M., J. Exp. Med. 189(11), 1999
PMID: 10359587
Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS Jr., Oncogene 19(9), 2000
PMID: 10713699
Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome.
Ruan Q, Kameswaran V, Tone Y, Li L, Liou HC, Greene MI, Tone M, Chen YH., Immunity 31(6), 2009
PMID: 20064450
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.
Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M., Cell 118(3), 2004
PMID: 15294155
NF-kappa B subunit-specific regulation of the interleukin-8 promoter.
Kunsch C, Rosen CA., Mol. Cell. Biol. 13(10), 1993
PMID: 8413215
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor.
Libermann TA, Baltimore D., Mol. Cell. Biol. 10(5), 1990
PMID: 2183031
NF-κB, inflammation, immunity and cancer: coming of age.
Taniguchi K, Karin M., Nat. Rev. Immunol. 18(5), 2018
PMID: 29379212
Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.
Jin R, Sterling JA, Edwards JR, DeGraff DJ, Lee C, Park SI, Matusik RJ., PLoS ONE 8(4), 2013
PMID: 23577181
Immune regulation of cancer.
Disis ML., J. Clin. Oncol. 28(29), 2010
PMID: 20516428
Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation.
Carcamo JM, Pedraza A, Borquez-Ojeda O, Golde DW., Biochemistry 41(43), 2002
PMID: 12390026
Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr., Mol. Cell. Biol. 17(7), 1997
PMID: 9199297
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T., J. Clin. Invest. 114(4), 2004
PMID: 15314694
The NF-kappaB family of transcription factors and its regulation.
Oeckinghaus A, Ghosh S., Cold Spring Harb Perspect Biol 1(4), 2009
PMID: 20066092
CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle.
Slotta C, Schluter T, Ruiz-Perera LM, Kadhim HM, Tertel T, Henkel E, Hubner W, Greiner JFW, Huser T, Kaltschmidt B, Kaltschmidt C., PLoS ONE 12(8), 2017
PMID: 28767691
NF-kappaB in the nervous system.
Kaltschmidt B, Kaltschmidt C., Cold Spring Harb Perspect Biol 1(3), 2009
PMID: 20066105
Increased survival from stage IV melanoma associated with fewer regulatory T Cells.
Baumgartner JM, Gonzalez R, Lewis KD, Robinson WA, Richter DA, Palmer BE, Wilson CC, McCarter MD., J. Surg. Res. 154(1), 2008
PMID: 19062042
Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation.
Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M., Cancer Cell 17(1), 2010
PMID: 20129250
The complexity of NF-κB signaling in inflammation and cancer.
Hoesel B, Schmid JA., Mol. Cancer 12(), 2013
PMID: 23915189
NF-KappaB in Long-Term Memory and Structural Plasticity in the Adult Mammalian Brain.
Kaltschmidt B, Kaltschmidt C., Front Mol Neurosci 8(), 2015
PMID: 26635522
Integrating cell-signalling pathways with NF-kappaB and IKK function.
Perkins ND., Nat. Rev. Mol. Cell Biol. 8(1), 2007
PMID: 17183360
Adult palatum as a novel source of neural crest-related stem cells.
Widera D, Zander C, Heidbreder M, Kasperek Y, Noll T, Seitz O, Saldamli B, Sudhoff H, Sader R, Kaltschmidt C, Kaltschmidt B., Stem Cells 27(8), 2009
PMID: 19544446
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.
Xia Y, Yeddula N, Leblanc M, Ke E, Zhang Y, Oldfield E, Shaw RJ, Verma IM., Nat. Cell Biol. 14(3), 2012
PMID: 22327365
Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.
Baud V, Karin M., Nat Rev Drug Discov 8(1), 2009
PMID: 19116625
Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.
Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA, Karin M., Nature 446(7136), 2007
PMID: 17377533
Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.
Basseres DS, Ebbs A, Levantini E, Baldwin AS., Cancer Res. 70(9), 2010
PMID: 20406971
1,8-Cineole potentiates IRF3-mediated antiviral response in human stem cells and in an ex vivo model of rhinosinusitis.
Muller J, Greiner JF, Zeuner M, Brotzmann V, Schafermann J, Wieters F, Widera D, Sudhoff H, Kaltschmidt B, Kaltschmidt C., Clin. Sci. 130(15), 2016
PMID: 27129189
NF-kappaB functions as a tumour promoter in inflammation-associated cancer.
Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y., Nature 431(7007), 2004
PMID: 15329734
Material in PUB:
Teil von PUB Eintrag
Heterogeneity of adult human stem cells in physiology and pathogenesis
Greiner J (2021)
Bielefeld: Universität Bielefeld.

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

PMID: 29673141
PubMed | Europe PMC

Suchen in

Google Scholar